Hypertension and COVID-19: current evidence and perspectives

G Gallo, V Calvez, C Savoia - High Blood Pressure & Cardiovascular …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …

Role of the renin–angiotensin–aldosterone and kinin–kallikrein systems in the cardiovascular complications of COVID-19 and long COVID

SL Cooper, E Boyle, SR Jefferson, CRA Heslop… - International Journal of …, 2021 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the virus responsible
for the COVID-19 pandemic. Patients may present as asymptomatic or demonstrate mild to …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Changes in blood pressure outcomes among hypertensive individuals during the COVID-19 pandemic: a time series analysis in three US healthcare organizations

H Gotanda, N Liyanage-Don, AE Moran… - …, 2022 - Am Heart Assoc
Background: The COVID-19 pandemic may have negatively affected medical care for and
self-management of chronic hypertension. We sought to examine the impact of the …

Causal associations and shared genetics between hypertension and COVID‐19

A Baranova, H Cao, F Zhang - Journal of Medical Virology, 2023 - Wiley Online Library
To evaluate the genetic relationship between hypertension and COVID‐19 and explore the
molecular pathways linking hypertension to COVID‐19. We performed genetic correlation …

Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study

A Gimeno-Miguel, K Bliek-Bueno, B Poblador-Plou… - PloS one, 2021 - journals.plos.org
Background Clinical outcomes among COVID-19 patients vary greatly with age and
underlying comorbidities. We aimed to determine the demographic and clinical factors …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Hypertension management before and under the COVID-19 pandemic: lessons and future directions

Y Nozato, K Yamamoto, H Rakugi - Hypertension Research, 2023 - nature.com
Hypertension is a significant risk factor for cardiovascular diseases. The prevalence of
hypertension and its complications is increasing yearly, yet it remains inadequately …

Impact of comorbidity on patients with COVID-19 in India: a nationwide analysis

P Singh, Y Bhaskar, P Verma, S Rana, P Goel… - Frontiers in Public …, 2023 - frontiersin.org
Background The emergence of coronavirus disease (COVID-19) as a global pandemic has
resulted in the loss of many lives and a significant decline in global economic losses. Thus …

Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship

SF de Medeiros, MMW Yamamoto… - Reviews in Endocrine …, 2022 - Springer
This comprehensive review aimed to evaluate the relationship between SARS-CoV-2
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …